June 2018 - Biologics by McKesson

Combination Therapy BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the Treatment of BRAF-mutant Melanoma, Available for Order at Biologics by McKesson

Jun 29, 2018 | Press Release

CARY, N.C. (June 29, 2018) — Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, has been selected by Array BioPharma, Inc. to be in the limited distribution network for the combination therapy BRAFTOVITM...

Combination Therapy BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the Treatment of BRAF-mutant Melanoma, Available for Order at Biologics by McKesson

Recent Posts

Archives